GIC-backed Chinese biopharma firm CStone raises $285m in HK IPO

CStone Pharmaceuticals, a Chinese biopharma firm backed by Singapore’s sovereign wealth fund GIC, has raised HK$2.2 billion ($285 million) in its initial public offering (IPO) in Hong Kong after selling 186.4 million shares at HK$12 apiece.